B Coudert Selected Research

B Coudert Research Topics

Disease

16	Breast Neoplasms (Breast Cancer) 12/2021 - 06/2001
11	Neoplasms (Cancer) 01/2020 - 06/2001
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 11/2001
4	Colorectal Neoplasms (Colorectal Cancer) 12/2012 - 01/2000
2	Pathologic Complete Response 01/2020 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2018 - 06/2001
2	Disease Progression 01/2012 - 01/2005
2	Cardiotoxicity 02/2011 - 03/2010
2	Carcinoma (Carcinomatosis) 10/2007 - 06/2000
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2003 - 11/2001
2	Pain (Aches) 11/2001 - 06/2001
1	Inflammatory Breast Neoplasms 01/2021
1	Unilateral Breast Neoplasms 10/2012
1	Adenocarcinoma 01/2012
1	Brain Neoplasms (Brain Tumor) 03/2010
1	Neutropenia 07/2007
1	Diarrhea 07/2007
1	Glioblastoma (Glioblastoma Multiforme) 05/2002
1	Ovarian Neoplasms (Ovarian Cancer) 03/2002
1	Tumor Lysis Syndrome 03/2002
1	Lung Neoplasms (Lung Cancer) 11/2001
1	Acute Pain 11/2001
1	Jaundice (Icterus) 06/2001
1	Fever (Fevers) 06/2001

Drug/Important Bio-Agent (IBA)

9	Trastuzumab (Herceptin)FDA Link 12/2021 - 01/2006
8	Docetaxel (Taxotere)FDA Link 07/2020 - 01/2005
3	taxaneIBA 01/2020 - 07/2007
3	human ERBB2 proteinIBA 01/2017 - 10/2009
3	Taxoids (Taxanes)IBA 07/2011 - 01/2006
3	Fluorouracil (Carac)FDA LinkGeneric 03/2002 - 01/2000
3	Leucovorin (Folinic Acid)FDA Link 03/2002 - 01/2000
2	NivolumabIBA 01/2022 - 01/2018
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 10/2012
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2012 - 01/2012
2	ErbB Receptors (EGF Receptor)IBA 01/2012 - 10/2007
2	Cisplatin (Platino)FDA LinkGeneric 01/2005 - 06/2001
2	acridine DACAIBA 02/2003 - 05/2002
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 02/2003 - 05/2002
2	DNA (Deoxyribonucleic Acid)IBA 02/2003 - 05/2002
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2001 - 01/2000
1	B7-H1 AntigenIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Monoclonal AntibodiesIBA 12/2021
1	Bevacizumab (Avastin)FDA Link 12/2021
1	PlatinumIBA 07/2020
1	Epidermal Growth Factor (EGF)IBA 01/2020
1	EnzymesIBA 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Hormones (Hormone)IBA 03/2017
1	Phenobarbital (Luminal)FDA Link 10/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2012
1	Estrogen ReceptorsIBA 10/2012
1	Carboplatin (JM8)FDA LinkGeneric 02/2011
1	AnthracyclinesIBA 02/2011
1	Tyrosine (L-Tyrosine)FDA Link 10/2007
1	Phosphotransferases (Kinase)IBA 10/2007
1	ixabepilone (BMS 247550)FDA Link 07/2007
1	Epothilones (Epothilone)IBA 07/2007
1	epothilone B (EPO906)IBA 07/2007
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2005
1	marimastatIBA 04/2003
1	Cytotoxins (Cytolysins)IBA 02/2003
1	MelatoninIBA 01/2002
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2001
1	ISIS 5132IBA 11/2001
1	Messenger RNA (mRNA)IBA 11/2001
1	raf KinasesIBA 11/2001
1	Opioid Analgesics (Opioids)IBA 11/2001
1	SolutionsIBA 06/2001
1	(L)-Isomer Glucose (L-Glucose)IBA 06/2001
1	CreatinineIBA 06/2001
1	N'- (2- chloroethyl)- N- (2- (methylsulfonyl)ethyl)- N'- nitrosoureaIBA 06/2000

Therapy/Procedure

12	Therapeutics 01/2021 - 03/2002
8	Drug Therapy (Chemotherapy) 07/2020 - 03/2002
8	Neoadjuvant Therapy 01/2020 - 10/2010
2	Radiotherapy 07/2020 - 09/2013
2	Chronotherapy 06/2003 - 03/2002
1	Immunotherapy 01/2022
1	Adjuvant Chemotherapy 09/2013
1	Mastectomy (Mammectomy) 10/2012
1	Treatment Delay 11/2001
1	Analgesia 11/2001